Your browser doesn't support javascript.
loading
A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia.
Ma, Leyuan; Shan, Yi; Bai, Robert; Xue, Liting; Eide, Christopher A; Ou, Jianhong; Zhu, Lihua J; Hutchinson, Lloyd; Cerny, Jan; Khoury, Hanna Jean; Sheng, Zhi; Druker, Brian J; Li, Shaoguang; Green, Michael R.
Afiliação
  • Ma L; Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Shan Y; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Bai R; Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Xue L; Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Eide CA; Howard Hughes Medical Institute, Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA.
  • Ou J; Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Zhu LJ; Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Hutchinson L; Department of Pathology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Khoury HJ; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA 30332, USA.
  • Sheng Z; Virginia Tech Carilion Research Institute, Roanoke, VA 24016, USA. Department of Biomedical Sciences and Pathobiology, Virginia Tech, Blacksburg, VA 24061, USA.
  • Druker BJ; Howard Hughes Medical Institute, Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, OR 97239, USA.
  • Li S; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA.
  • Green MR; Howard Hughes Medical Institute, Programs in Gene Function and Expression and Molecular Medicine, University of Massachusetts Medical School, Worcester, MA 01605, USA. michael.green@umassmed.edu.
Sci Transl Med ; 6(252): 252ra121, 2014 Sep 03.
Article em En | MEDLINE | ID: mdl-25186176
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Limite: Animals / Humans Idioma: En Ano de publicação: 2014 Tipo de documento: Article